Approach to anaemia in gastrointestinal disease: A position paper by the ESPGHAN Gastroenterology Committee
- PMID: 39783775
- PMCID: PMC11874238
- DOI: 10.1002/jpn3.12454
Approach to anaemia in gastrointestinal disease: A position paper by the ESPGHAN Gastroenterology Committee
Abstract
Anaemia is a frequent consequence of many gastrointestinal (GI) diseases in children and it can even be the initial presenting symptom of underlying chronic GI disease. The definition of anaemia is age and gender-dependent and it can be classified based on pathophysiology, red cell morphology, and clinical presentation. Although nutritional deficiencies, including GI malabsorption of nutrients and GI bleeding, play a major role, other pathophysiologic mechanisms seen in chronic GI diseases, whether inflammatory (e.g., inflammatory bowel disease) or not (e.g., coeliac disease and dysmotility), are causing anaemia. Drugs, such as proton pump inhibitors, mesalamine, methotrexate and sulfasalazine, are also a potential cause of anaemia. Not uncommonly, due to a combination of factors, such as iron deficiency and a chronic inflammatory state, the underlying pathophysiology may be difficult to decipher and a broad diagnostic work-up is required. The goal of treatment is correction of anaemia by supplementation of iron and vitamins. The first therapeutic step is to treat the underlying cause of anaemia including bleeding control, restoration of intestinal integrity and reduction of inflammatory burden. The route of iron and vitamin supplementation is guided by the severity of anaemia.
Keywords: algorithm; diagnosis; therapy.
© 2025 The Author(s). Journal of Pediatric Gastroenterology and Nutrition published by Wiley Periodicals LLC on behalf of European Society for Pediatric Gastroenterology, Hepatology, and Nutrition and North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition.
Conflict of interest statement
Osvaldo Borrell received the last 3 years of consultation and lecture fees from Danone, Nutricia and Mead Johnson. Javier Martin‐de‐Carp received the last 3 years of consultation and lecture fees from Abbott, Abbvie, Adacyte, Janssen, Nestle and Norgine. Erasmo Miele received the last 3 years of grants/research support from Nestle Italy and Nutricia Italy and received payment/honorarium for lectures from Dicofarm, Ferring and Shire‐Takeda. Zrinjka Misak received the last 3 years of consultation and lecture fees from Milsing, Sandoz and Hipp. Christos Tzivinikos received the last 3 years of payment/honorarium for lecture/consultation from Sanofi, Takeda, Nestle, Nutricia and Abbvie. The remaining authors declare no conflicts of interest.
Figures


References
-
- World Health Organization . Global Health Observatory Data Repository: Anaemia in Children <5 Years by Region. 2016. https://apps.who.int/gho/data/view.main.ANEMIACHILDRENREGv.
-
- World Health Organization . Nutritional Anaemias: Report of a WHO Scientific Group. 1968. https://appswho.int/iris/bitstream/handle/10665/40707/WHO_TRS_405.pdf?se.... - PubMed
-
- World Health Organization . Haemoglobin Concentrations for the Diagnosis of Anaemia and Assessment of Severity. 2011. https://apps.who.int/iris/bitstream/handle/10665/85839/WHO_NMH_NHD_MNM_1....
-
- Matysiak M. Anemia in children: a pediatrician's view. Acta Haematol Pol. 2021;52:402‐405.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical